A Look at Global Investor Charles De Vaulx's Top 5 Holdings

Author's Avatar
Dec 03, 2014
Article's Main Image

Charles De Vaulx of the IVA Funds reported his third quarter holdings this past week. This year the IVA Funds will celebrate their sixth year in the business. The fund maintains a dual investment approach which is split into short- and long-term investments. IVA reports that their short-term (12 to 18 months) investments are in order to preserve capital while their longer term (5 to 10 years) they try to perform better that their equity benchmark. The fund also reported that over the past five years, they achieved both of these goals with their investments.

Over the past quarter Charles De Vaulx in his IVA Worldwide Fund bought three new stocks bringing the total number of stocks to 97 valued at $5.377 billion. The following five companies are De Vaulx’s largest holdings as of the close of the third quarter.

Astellas Pharma (TSE:4503, Financial)

The guru’s largest holding is in Astellas Pharma where he holds on to 27,439,100 shares of the company’s stock. His holdings make up for 7.6% of his total portfolio and 1.24% of the company’s shares outstanding.

The guru cut his holdings a minor -0.14% over the past quarter by selling 37,900 shares of the company’s stock. He sold these shares near the estimated average quarterly price of ¥1469.83 per share, and since then the price per share has increased 16.6%.

Charles De Vaulx’s historical holdings as of the close of the third quarter:

03May20171241581493833318.png

Astellas Pharma Inc is engaged in the business of manufacturing, marketing and import/export of pharmaceuticals. The company's businesses are segmented into pharmaceutical and other.

Astellas Pharma’s historical revenue and net income:

03May20171241581493833318.png

The analysis on Astellas Pharma reports that the company’s price is sitting near a 5-year high, its dividend yield is near a 5-year low and the company currently holds no debt.

The Peter Lynch Chart suggests that the company is currently overvalued:

03May20171241591493833319.png

Astellas Pharma has a market cap of ¥3765.88 billion. Its shares are currently trading at around ¥1713.50 with a P/E ratio of 18.60, a P/S ratio of 1.94 and a P/B ratio of 2.47. The company currently holds a dividend yield of around 3.94%.

Nestle SA (XSWX:NESN, Financial)

De Vaulx’s second largest position over the past quarter was in Nestle SA where he holds on to 4,362,184 shares of the company’s stocks. His holdings make up for 6% of his total portfolio and 0.14% of the company’s shares outstanding.

The guru increased his holdings by 1.68% over the past quarter by purchasing a total of 72,060 shares of the company’s stock. The guru added these shares to his holdings near the estimated quarterly price range of CHF69.71 per share. Since then the price per share has increased approximately 4.1%.

Charles De Vaulx’s historical holding history:

03May20171242001493833320.png

Nestle SA manufactures and markets food products. The Company's product line includes milk, chocolate, confectionery, creamer, coffee, food seasoning, bottled water and pet foods among others.

Nestle’s historical revenue and net income:

03May20171242001493833320.png

The analysis on the company reports that the revenue has been in decline over the past five years, the company has issued CHF6.3 billion of debt over the past year, the operating margin is expanding and P/E and P/B ratios are nearing 1-year lows.

The Peter Lynch Chart suggests that the company is currently overvalued:

03May20171242001493833320.png

Nestle SA has a market cap of CHF231.41billion. Its shares are currently trading at around CHF72.55 with a P/E ratio of 23.20 a P/S ratio of 2.51 and a P/B ratio of 3.49. The company had an annual average earnings growth of 6.3% over the past ten years.

Berkshire Hathaway (BRK.A, Financial)

The guru’s third largest holding goes to Berkshire Hathaway where he maintains 1,379 shares of the company’s stock. His position makes up for 5.3% of his total assets managed and 0.08% of the company’s shares outstanding.

Charles De Vaulx increased his holdings 1.47% over the past quarter by purchasing a total of 20 shares. The guru added these shares near the estimated average quarterly price of $200,211.20 per share. Since then the price per share is trading up approximately 11.6%.

De Vaulx’s historical holding history:

03May20171242011493833321.png

Berkshire Hathaway is a conglomerate holding company owning subsidiaries engaged in a number of business activities, including property and casualty insurance and reinsurance, utilities and energy, finance, manufacturing, service and retailing.

Berkshire Hathaway’s historical revenue and earnings growth:

03May20171242011493833321.png

The analysis on Berkshire Hathaway reports that the company’s price is near a 10-year high, it has shown predictable revenue and earnings growth and its operating margin is expanding.

The Peter Lynch Chart suggests that the company is currently overvalued:

03May20171242021493833322.png

Berkshire Hathaway has a market cap of $363.77 billion. Its shares are currently trading at around $222,525 with a P/E ratio of 16.90, a P/S ratio of 1.80 and a P/B ratio of 1.30. Berkshire Hathaway had an annual average earnings growth of 9.30% over the past ten years.

GuruFocus rated Berkshire Hathaway the business predictability rank of 3-star.

Genting Malaysia (XKLS:4715)

Genting Malaysia is new to the guru’s top five holdings. De Vaulx holds on to 147,412,700 shares of the company’s stock. This position makes it his fourth largest holding as well as 3.5% of his total assets managed. This holding also makes up for 2.60% of the company’s shares outstanding.

Over the past quarter the guru cut his holdings -1.24% by selling a total of 1,849,100 shares of the company’s stock. He sold these holdings near the estimated average quarterly price of $4.30 per share. Since then the price per share has dropped an additional -4.7%.

Check out De Vaulx’s historical holdings here:

03May20171242021493833322.png

Genting Malaysia is engaged in a tourist resort business at Genting Highlands and its activities cover leisure and hospitality services, which comprise gaming, hotel, entertainment and amusement. Its subsidiaries are engaged in the operation of casinos, property development and management, leisure and hospitality service

Genting Malaysia’s historical revenue and net income:

03May20171242031493833323.png

The analysis on Genting Malaysia reports that the company’s revenue per share has slowed down over the past year, its dividend yield is near a 2-year low and its price is near a 10-year high. The analysis also notes that the company has issued MYR426.176 million of debt and that its asset growth is currently faster than its revenue growth.

There are four gurus holding a position in Genting Malaysia. Check out their holding histories here.

The Peter Lynch Chart suggests that the company is currently overvalued:

03May20171242031493833323.png

Genting Malaysia has a market cap of $23.25 billion. Its shares are currently trading at around $4.14 with a P/E ratio of 18.10 and a P/S ratio of 2.81. The company had an annual average earnings growth of 4.50% over the past five years.

Oracle Corp (ORCL, Financial)

The guru’s fifth largest holding goes to Oracle where he maintains 4,440,586 shares of the company’s stock. His position makes up for 3.2% of his total portfolio and 0.10% of the company’s shares outstanding.

Over the past quarter the guru increased his position 1.53% by purchasing 66,778 shares of the company’s stock. The guru bought these shares in the quarterly price range of $35.84 to $40.91, with an estimated average quarterly price of $38.06 per share. Since then the price per share is trading up approximately 10%.

De Vaulx’s holding history of Oracle as of the third quarter:

03May20171242031493833323.png

Oracle provides technologies of cloud computing, including database and middleware as well as web-based applications, virtualization, clustering and systems management. It provides cloud services as well as software and hardware products to other cloud service providers, both public and private.

Oracle’s historical revenue and net income:

03May20171242041493833324.png

The analysis on Oracle reports that the company’s revenue has slowed down over the past year, its price is near a 10-year high, its operating margin is expanding and its dividend yield is also near a 5-year high.

The Peter Lynch Chart suggests that the company is currently undervalued:

03May20171242041493833324.png

Oracle Corporation has a market cap of $187 billion. Its shares are currently trading at around $42.40 with a P/E ratio of 17.60, a P/S ratio of 5.00 and a P/B ratio of 4.20. The company had an annual average earnings growth of 18% over the past ten years.

GuruFocus rated Oracle the business predictability rank of 4.5-star.

Check out Charles De Vaulx’s full third quarter portfolio here.

Try a 7-day premium membership trial here.